Search results
Kevin Jonas says it's 'time to heal' after having skin cancer removed from his forehead. What is...
Yahoo Canada Style· 9 hours agoEven with treatment, it's possible for BCC to reoccur, and it does increase your risk of developing...
When to get your moles checked, after Kevin Jonas recovers from surgery
Press Association News via AOL· 13 hours ago“Basal cell carcinoma is either a flat...skin that bleeds or is painful but also a reddish lump.”...
MyMichigan Health: ABCDE of Melanoma
Midland Daily News· 4 days agoSkin cancer is the most common type of cancer in the United States, and it's estimated that one in five Americans will develop
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 1 day agoThe companies are also testing the combo in patients with melanoma, non-small cell lung cancer,...
Congenital Pigment Disorders May Need Special Management
Medscape· 21 hours agoCongenital disorders of pigmentation are numerous and can have mild to severe effects, and some have...
Arkansas woman shares story of winning battle with tongue cancer
KTHV Little Rock· 2 days agoAnn Gibbs and her husband Matt have become familiar with the UAMS Winthrop P. Rockefeller Cancer...
Replimune (REPL) Gains on Positive Data From Melanoma Study
Zacks via Yahoo Finance· 7 days agoReplimune's (REPL) lead pipeline candidate RP1, in combination with Opdivo, leads to an overall...
Inebilizumab 'MITIGATES' Flare Risk in IgG4-Related Disease
Medscape· 7 days agoInebilizumab-cdon reduced the risk for flares by 87% in patients with IgG4-RD, the MITIGATE study showed.
Lichen Planopilaris: Prevalence, Treatments in the US
Medscape· 2 days agoMost patients diagnosed with LPP received at least one type of medication, most commonly...
Galectin Therapeutics (NASDAQ:GALT) Stock Price Crosses Above Two Hundred Day Moving Average of...
ETF DAILY NEWS· 5 days agoShares of Galectin Therapeutics Inc. (NASDAQ:GALT – Get Free Report) passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $2.33 and traded ...